TGFB2 and gastric adenocarcinoma: For example, using the TIMER database found that TGF-β2 had the ability to regulate immune cell recruitment and activation in gastric adenocarcinoma (STAD), and it might be an important regulator of immune cell infiltration and a valuable prognostic biomarker in GC patients (331).